Cargando…

Targeting Glycogen Synthase Kinase-3β for Therapeutic Benefit against Oxidative Stress in Alzheimer's Disease: Involvement of the Nrf2-ARE Pathway

Specific regions of the Alzheimer's disease (AD) brain are burdened with extracellular protein deposits, the accumulation of which is concomitant with a complex cascade of overlapping events. Many of these pathological processes produce oxidative stress. Under normal conditions, oxidative stres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kanninen, Katja, White, Anthony R., Koistinaho, Jari, Malm, Tarja
Formato:	Texto
Lenguaje:	English
Publicado:	SAGE-Hindawi Access to Research 2011
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3100734/ https://www.ncbi.nlm.nih.gov/pubmed/21629716 http://dx.doi.org/10.4061/2011/985085

Ejemplares similares

Glycogen Synthase Kinase-3β: A Mediator of Inflammation in Alzheimer's Disease?
por: Koistinaho, Jari, et al.
Publicado: (2011)

Utilization of APPswe/PS1dE9 Transgenic Mice in Research of Alzheimer's Disease: Focus on Gene Therapy and Cell-Based Therapy Applications
por: Malm, Tarja, et al.
Publicado: (2011)

Glycogen Synthase Kinase-3
por: Crouch, Peter, et al.
Publicado: (2011)

Pyrrolidine dithiocarbamate activates the Nrf2 pathway in astrocytes
por: Liddell, Jeffrey R., et al.
Publicado: (2016)

Animal Models of Alzheimer’s Disease: Utilization of Transgenic Alzheimer’s Disease Models in Studies of Amyloid Beta Clearance
por: Malm, Tarja, et al.
Publicado: (2012)

Human intravenous immunoglobulin provides protection against Aβ toxicity by multiple mechanisms in a mouse model of Alzheimer's disease
por: Magga, Johanna, et al.
Publicado: (2010)

Increased Expression and Activity of Brain Cortical cPLA2 Due to Chronic Lipopolysaccharide Administration in Mouse Model of Familial Alzheimer’s Disease
por: Gynther, Mikko, et al.
Publicado: (2022)

Effects of human intravenous immunoglobulin on amyloid pathology and neuroinflammation in a mouse model of Alzheimer’s disease
por: Puli, Lakshman, et al.
Publicado: (2012)

Targeting Nrf2 to Suppress Ferroptosis and Mitochondrial Dysfunction in Neurodegeneration
por: Abdalkader, Moataz, et al.
Publicado: (2018)

Lack of collagen XV is protective after ischemic stroke in mice
por: Dhungana, Hiramani, et al.
Publicado: (2017)

ADAMTS-4 promotes neurodegeneration in a mouse model of amyotrophic lateral sclerosis
por: Lemarchant, Sighild, et al.
Publicado: (2016)

Erratum to: ADAMTS-4 promotes neurodegeneration in a mouse model of amyotrophic lateral sclerosis
por: Lemarchant, Sighild, et al.
Publicado: (2016)

Biometals in rare neurodegenerative disorders of childhood
por: Parker, Sarah J., et al.
Publicado: (2013)

Metabolomic and lipidomic changes triggered by lipopolysaccharide-induced systemic inflammation in transgenic APdE9 mice
por: Puris, Elena, et al.
Publicado: (2021)

Glycogen Synthase Kinase 3: A Point of Integration in Alzheimer's Disease and a Therapeutic Target?
por: Mondragón-Rodríguez, Siddhartha, et al.
Publicado: (2012)

Kinase Inhibitor Screening Identifies Cyclin-Dependent Kinases and Glycogen Synthase Kinase 3 as Potential Modulators of TDP-43 Cytosolic Accumulation during Cell Stress
por: Moujalled, Diane, et al.
Publicado: (2013)

Production of monocytic cells from bone marrow stem cells: therapeutic usage in Alzheimer’s disease
por: Magga, Johanna, et al.
Publicado: (2012)

Sulfosuccinimidyl oleate sodium is neuroprotective and alleviates stroke-induced neuroinflammation
por: Dhungana, Hiramani, et al.
Publicado: (2017)

PROTAC-Induced Glycogen Synthase Kinase 3β Degradation as a Potential Therapeutic Strategy for Alzheimer’s Disease
por: Guardigni, Melissa, et al.
Publicado: (2023)

Regulation of the Nrf2 Pathway by Glycogen Synthase Kinase-3β in MPP(+)-Induced Cell Damage
por: Armagan, Güliz, et al.
Publicado: (2019)

Increased iron content in the heart of the Fmr1 knockout mouse
por: Talvio, Karo, et al.
Publicado: (2021)

Glycogen Synthase Kinase 3 Inhibitors in the Next Horizon for Alzheimer's Disease Treatment
por: Martinez, Ana, et al.
Publicado: (2011)

Regulation of Cell Survival Mechanisms in Alzheimer's Disease by Glycogen Synthase Kinase-3
por: Mines, Marjelo A., et al.
Publicado: (2011)

Granulocyte colony stimulating factor attenuates inflammation in a mouse model of amyotrophic lateral sclerosis
por: Pollari, Eveliina, et al.
Publicado: (2011)

Apoptosis of cardiomyocytes in diabetic cardiomyopathy involves overexpression of glycogen synthase kinase-3β
por: Wu, Wei, et al.
Publicado: (2019)

Glycogen synthase kinase 3β in tumorigenesis and oncotherapy
por: He, Rui, et al.
Publicado: (2020)

Involvement of the Glycogen Synthase Kinase-3 Signaling Pathway in TBI Pathology and Neurocognitive Outcome
por: Dash, Pramod K., et al.
Publicado: (2011)

Long-term interleukin-33 treatment delays disease onset and alleviates astrocytic activation in a transgenic mouse model of amyotrophic lateral sclerosis
por: Korhonen, Paula, et al.
Publicado: (2019)

Interactomes of Glycogen Synthase Kinase-3 Isoforms
por: Cormier, Kevin W., et al.
Publicado: (2023)

Unravelling the Role of Glycogen Synthase Kinase-3 in Alzheimer’s Disease-Related Epileptic Seizures
por: Lin, Runxuan, et al.
Publicado: (2020)

Loss of Cln5 causes altered neurogenesis in a mouse model of a childhood neurodegenerative disorder
por: Savchenko, Ekaterina, et al.
Publicado: (2017)

Retinal Degeneration In A Mouse Model Of CLN5 Disease Is Associated With Compromised Autophagy
por: Leinonen, Henri, et al.
Publicado: (2017)

Glycogen Synthase Kinase 3β in Cancer Biology and Treatment
por: Domoto, Takahiro, et al.
Publicado: (2020)

Glycogen Synthase Kinase 3β Inhibition as a Therapeutic Approach in the Treatment of Endometrial Cancer
por: Yin, Yan, et al.
Publicado: (2013)

Glycogen synthase kinase 3β as a potential therapeutic target in synovial sarcoma and fibrosarcoma
por: Abe, Kensaku, et al.
Publicado: (2019)

Two homolog wheat Glycogen Synthase Kinase 3/SHAGGY - like kinases are involved in brassinosteroid signaling
por: Bittner, Thomas, et al.
Publicado: (2015)

Glycogen Synthase Kinase-3β Is a Negative Regulator of Cardiomyocyte Hypertrophy
por: Haq, Syed, et al.
Publicado: (2000)

Aberrant Glycogen Synthase Kinase 3β Is Involved in Pancreatic Cancer Cell Invasion and Resistance to Therapy
por: Kitano, Ayako, et al.
Publicado: (2013)

Glycogen Synthase Kinase-3: A Promising Therapeutic Target for Fragile X Syndrome
por: Mines, Marjelo A., et al.
Publicado: (2011)

Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinoma
por: Bilim, V, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_pbiodeu02btubch2u31mt90dgb